A bull market is here, but not every stock is benefiting. Some players remain in the doldrums. It's up to investors to decide whether those left behind are likely to remain there or make top buying opportunities today that could deliver great rewards down the road. Wall Street is particularly enthusiastic about two beaten-down biotech stocks that soared in the earlier days of the pandemic. These two developed coronavirus vaccine candidates, and investors were betting they could eventually commercialize the ...